pylori. The complete genome sequence of H. pylori strain 26695 has been published 2 . The genome contains 1,667,867 bp and 1590 predicted coding regions with an average G+C content of 39%. This work should have a profound impact on our understanding of H. pylori with respect to genetics, physiology, pathogenicity and evolution. In addition, this work should also lead to identification of potential new drug targets for eradication of this pathogen. Due to space limitation, this mini-review will outline current advances in the molecular genetics of H. pylori with emphasis on genomic diversity as well as its importance in molecular diagnosis and the pathogenicity of H. pylori.
Genes and genome of H. pylori

Overview
The size of the H. pylori chromosome is estimated to be from 1.68-1.73 Mb 3 , determined by PFGE-restriction fragment length analysis of 29 H. pylori isolates. The genome sequence contains a relatively low GC content 4 , an average of 32.5 mol% G+C with a range of 34.1-37.5 mol%. At least 50 genes have been cloned from H. pylori. The important house-keeping genes include 16S 5 , 23S and 5S ribosomal RNA (rRNA) genes, gyrA involved in DNA replication 6 , recA responsible for homologous DNA recombination 7 and ftsH essential for cell viability 8 . The H. pylori genome contains two copies of each of the 5S, 23S and 16S rRNA genes 9 . The 5S and 23S genes are often linked together, whereas in some strains the 16S rRNA gene is separated from the 23S/5S rRNA gene cluster 9 . Several genetic determinants have been implicated in virulence of H. pylori, including a vacuolating cytotoxin gene (vacA), a cytotoxinassociated gene (cagA), flagellin genes (flaA, flaB), a. urease gene cluster (ureA and ureB encoding structural subunits, ureC and ureD of unknown functions, ureE, ureF ureG, ureH and urel required for urease activity) and picB having a potential ability to induce the production of interleukin-8 (IL-8) by gastric epithelial cells. These studies were recently reviewed by Labigne . This new H. pylori IS605 contains two genes tnpA and tnpB which likely encode transposases. The tnpA product exhibits significant sequence similarity to the transposase of IS200 from E. coli, whereas the deduced amino acid sequence of tnpB is similar to the transposase found in the thermophilic bacterium PS3. A short inverted repeat with a core sequence CTTTAG flanks IS605.
Approximately 50% of H. pylori strains carry plasmids whose sizes range from 1.5-40 kb 13 and whose restriction patterns are highly variable. These plasmids are cryptic, i.e. not found to be associated with any phenotype. The complete nucleotide sequences of two H. pylori plasmids pHPK255 (1.5 kb) and pHPM180 (3.5 kb) have been determined. The deduced Rep protein of HPK255 shares sequence similarity with the Rep proteins from a group of small plasmids utilizing the 'rolling-circle-replication' mechanism found in Gram-positive bacteria 14 , whereas the deduced Rep protein (ORF1) of pHPM180 has significant sequence similarity to the Rep proteins which replicate by the 'theta-type' mechanism, suggesting that pHPM180 could also employ such a mechanism for its replication 13 . Only two homologous regions between the nucleotide sequences of pHPM180 and pHPK255 have been found, which are restricted to the second long direct repeat of pHPM180 13 .
Sequence diversity
Genetic studies have revealed a unique feature of the H. pylori genome, high genomic variability. Upon Nrul and Notl digestion followed by PFGE, all 29 different strains examined gave discrete restriction fragment profiles 3 .
Comparison of the genetic maps of five H. pylori strains demonstrated that there is no characteristic arrangement of 17 known genes on the chromosome conserved by these strains 9 (macrodiversity). DNA sequence diversity within this gastric pathogen was also demonstrated by using arbitrary-primer PCR 15 . Sixty independent clinical isolates could be distinguished from one other by a single 'random amplified polymorphic DNA' (RAPD) primer.
Distribution of the cag region among different H. pylori strains is highly variable 11 . Forty strains could be divided into eight groups. Comparison of nucleotide and amino acid sequences of a 0.73 kb region of vacA revealed 88-97% sequence identity for both nucleotide and amino acid sequences between vacA* or vacA~ strains, whereas the degree of sequence identity between vacA* and vacA~ strains showed a significant decrease (-70% at the nucleotide level and -60% at the amino acid level) 20 . Further sequence analyses revealed the presence of five vacA subtypes within 59 strains, of which three signal sequence (namely sla, sib and s2) and two middle region motifs (ml and ml) were identified. Fifty-nine strains can be grouped by combination of signal sequence and middle region motifs into 5 types 20 : sla/ml (8), sla/m2 (12), slb/ml (14) , slb/m2 (6) and s2/m2 (19) .
Mechanisms causing genomic diversity are poorly understood at present. For macrodiversity, one hypothesis suggests that this diversity reflects a long evolutionary association with the human host 9 . Different strains remain within each individual human and his/her offspring for many generations and may independently undergo evolution. Alternatively, the diversity could result from gene re-arrangement within the chromosome caused by transposon-mediated gene mobility and recombination between repeated sequences 9 . On the other hand, microdiversity in H. pylori may result from two mechanisms: either by a progressive accumulation of point mutations in different strains over time or by horizontal gene transfer followed by allelic exchange between strains 9 . However, there is no solid evidence so far to support any of the above hypotheses to explain either macrodiversity or microdiversity.
Molecular typing of H. pylori
Molecular diagnosis and typing of H. pylori can provide information valuable for epidemiological and clinical studies, to appreciate population genetic structure, and to understand evolution of the microorganism. Sensitive and efficient techniques are essential for such purposes. Based on the high degree of genomic variability within H. pylori strains, various molecular techniques have been developed to differentiate clinical isolates.
Ribotyping 21
The principle of this method is that chromosomal DNA from different H. pylori strains are completely digested by selected restriction endonucleases (e.g. HindBl, HaeTR and Dral for H. pylori) and subsequently such restriction digestion patterns of the ribosomal RNA (rRNA) genes are visualized by hybridization with either radioactively or nonradioactively labeled specific DNA or RNA probes. This technique has been successfully applied in typing clinical isolates of H. pylori.
Restriction fragment length polymorphism (RFLP)
Intact chromosomal DNA is digested by restriction endonucleases and separated by pulsed-field gel electrophoresis (PFGE). Genetic maps can be constructed by hybridization of the restriction fragments with DNA probes prepared from known genes 3 -9 .
PCR-RFLP
DNA fragments are first amplified using PCR with primers generated from known genes, followed by restriction digestion. H. pylori strains are differentiated by this technique in the urease genes including ureA, ureB, ureC and wreD 15 ' 17 .
Arbitrarily primed PCR (AP-PCR) or random amplified polymorphic DNA (RAPD)
This technique involves amplification of random DNA fragments with primers consisting of arbitrary nucleotide sequences. Profiles of randomly amplified DNA fragments can discriminate among strains 15 .
PCR-DNA sequencing typing
This technique is based on the PCR amplification of a gene known to be polymorphic and common to all H. pylori strains. Subsequently, the nucleotide sequences of the fragments amplified from different isolates are determined and compared by direct DNA sequencing 19 " 20 .
Direct PCR typing
This method has recently been developed to detect so-called ulcerogenic strains based on the representative motifs in vacA or cagA 10 . Typespecific primers can be generated from the individual motifs including sla, sib, s2, ml and m2 and then used to diagnose types of clinical isolates by PCR. In addition, since approximately 45% of H. pylori strains contain the cagA gene, which is considered to be a marker of ulcer-producing strains, primers derived from cagA can be easily used to distinguish cagA* and cagA' strains.
The standard protocols for each of these methods are reproducible and available in the recent book edited by Clayton and Mobley
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. Readers should be aware that although emerging evidence suggests that the types of the vac A motifs are associated with clinical outcomes caused by corresponding H. pylori strains 23 , we believe that these data are still preliminary and further work is required to confirm a definite link. As a result, at present caution is advised before the techniques based on the vacA motif divergence are widely applied to clinical practice.
Key points for clinical practice
• In the past 14 years, genetic studies have considerably increased our understanding of this important human pathogen, including pathogenicity, virulence factors and pathogen-host interaction using animal models and in vitro mutagenesis techniques.
• The discovery of high genomic variability in H. pylori offers simple, accurate and efficient molecular typing techniques which are useful in both epidemiological and clinical studies.
• Importantly, some exciting progress has been made on genetic diversity-pathogenicity relationships among H. pylori strains. For example, H. pylori strains containing sla type vacA are more highly associated with severe gastric inflammation and duodenal ulceration (89% of 18 patients with sla strains) than vac A s2 strains which are associated with less inflammationary and ulcerous presentations (20% of 10 patients with s2 strains) 23 .
• The types of the PAI present in H. pylori may also contribute to the pathogenicity, since some of the genes in this region are involved in induction of a pro-inflammatory cytokine IL-8 in gastric epithelial cells in vitro 11 .
• Further studies on whether or not genetic diversity in H. pylori is directly related to pathogenicity would explain, at least in part, why only approximately 10% of people world-wide carrying this pathogen develop ulcers (80-90% of a total population infected in developing countries and about 50% of 50-year-old people infected in industrialized countries).
• Eventually, molecular studies may answer important public health issues such as who should be treated, when intervention should begin and what are the most efficient therapies to eradicate this gastric pathogen.
